We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+1.61%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$71.7B
AUM Growth
+$2.34B
Cap. Flow
+$1.49B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.97%
Holding
3,809
New
183
Increased
1,708
Reduced
1,572
Closed
206

Sector Composition

Rank Sector Weight
1 Technology 10.59%
2 Financials 9.51%
3 Healthcare 8.04%
4 Industrials 6.62%
5 Communication Services 5.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VET icon
1176
Vermilion Energy
VET
$1.75B
$5.32M 0.01%
318,966
+4,797
+2% +$83.3K
FFIV icon
1177
F5
FFIV
$23.2B
$5.3M 0.01%
37,732
+7,230
+24% +$1,000K
FAF icon
1178
First American
FAF
$7.37B
$5.29M 0.01%
89,717
+58,246
+185% +$3.33M
NLY icon
1179
Annaly Capital Management
NLY
$17.3B
$5.29M 0.01%
150,316
+34,839
+30% +$1.26M
SA
1180
Seabridge Gold
SA
$3.36B
$5.28M 0.01%
417,975
-5,614
-1% -$79.8K
SYNH
1181
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$5.28M 0.01%
99,220
-4,264
-4% -$219K
AAL icon
1182
American Airlines Group
AAL
$9.93B
$5.27M 0.01%
195,258
+9,128
+5% +$267K
SHYG icon
1183
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.59B
$5.26M 0.01%
113,227
+7,196
+7% +$334K
BWXT icon
1184
BWX Technologies
BWXT
$15.5B
$5.26M 0.01%
91,994
+42,441
+86% +$2.37M
GHY
1185
PGIM Global High Yield Fund
GHY
$479M
$5.25M 0.01%
365,716
-123,320
-25% -$1.77M
LOGM
1186
DELISTED
LogMein, Inc.
LOGM
$5.25M 0.01%
74,002
-3,328
-4% -$238K
HOPE icon
1187
Hope Bancorp
HOPE
$1.79B
$5.25M 0.01%
366,006
+4,055
+1% +$56.8K
SONY icon
1188
Sony
SONY
$140B
$5.24M 0.01%
443,240
-1,740
-0.4% -$19.6K
GEF icon
1189
Greif
GEF
$4.97B
$5.23M 0.01%
138,142
+18,160
+15% +$633K
TECH icon
1190
Bio-Techne
TECH
$11.2B
$5.23M 0.01%
106,948
+11,532
+12% +$578K
IAE
1191
Voya Asia Pacific High Dividend Equity Income Fund
IAE
$92.9M
$5.23M 0.01%
616,610
+34,746
+6% +$294K
DEI icon
1192
Douglas Emmett
DEI
$1.93B
$5.21M 0.01%
121,696
-7,377
-6% -$305K
PCH
1193
DELISTED
PotlatchDeltic
PCH
$5.21M 0.01%
126,871
+56,314
+80% +$2.18M
E icon
1194
ENI
E
$79.4B
$5.16M 0.01%
169,355
-48,682
-22% -$1.51M
SON icon
1195
Sonoco
SON
$5.72B
$5.14M 0.01%
88,381
+25,384
+40% +$1.51M
RFFC icon
1196
ALPS Active Equity Opportunity ETF
RFFC
$30.8M
$5.12M 0.01%
155,214
-3,696
-2% -$122K
DPZ icon
1197
Domino's
DPZ
$11.5B
$5.12M 0.01%
20,925
-9,106
-30% -$2.26M
FTAI icon
1198
FTAI Aviation
FTAI
$22.1B
$5.11M 0.01%
395,121
+27,303
+7% +$355K
EME icon
1199
Emcor
EME
$35.7B
$5.11M 0.01%
59,297
+21,745
+58% +$1.85M
AMRN
1200
Amarin Corp
AMRN
$298M
$5.1M 0.01%
16,835
+7,365
+78% +$2.57M

Similar funds

Raymond James & Associates's Q3 2019 Portfolio in Review

As of Q3 2019, Raymond James & Associates held 3,809 positions worth $71.7B, up 3.4% from $69.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Raymond James & Associates's Q3 2019 filing shows 183 new, 1,708 increased, 1,572 reduced and 206 closed positions. Its largest new stake was Change Healthcare Inc. Common Stock: 949,970 shares worth $11.5M. The largest sale was Microchip Technology, an estimated $155M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q3 2019 buy was Change Healthcare Inc. Common Stock: 949,970 shares worth $11.5M.
  • Raymond James & Associates added most to Comcast in Q3 2019, an estimated $203M increase.
  • Raymond James & Associates's biggest Q3 2019 reduction was Microchip Technology, cutting an estimated $155M.
  • Raymond James & Associates fully exited Anadarko Petroleum in Q3 2019, selling an estimated $89.3M.
  • Raymond James & Associates's ten largest holdings make up 22% of its $71.7B portfolio in Q3 2019.
  • Raymond James & Associates opened 183 new positions and closed 206 in Q3 2019.
  • Raymond James & Associates's portfolio value rose 3.4% quarter-over-quarter to $71.7B.

Based on Raymond James & Associates's 13F filing for Q3 2019, filed 7 Nov 2019.